Target Name: OR6B2
NCBI ID: G389090
Review Report on OR6B2 Target / Biomarker Content of Review Report on OR6B2 Target / Biomarker
OR6B2
Other Name(s): Olfactory receptor OR2-1 | OR2-1 | Olfactory receptor family 6 subfamily B member 2 | Olfactory receptor, family 6, subfamily B, member 2 pseudogene | OR6B2P | olfactory receptor OR2-1 | OR6B2_HUMAN | olfactory receptor family 6 subfamily B member 2 | Olfactory receptor 6B2 | olfactory receptor, family 6, subfamily B, member 2 pseudogene

Olfactory receptor OR6B2: A Potential Drug Target and Biomarker

Smell is a crucial sense that enables us to identify and remember various objects, such as food, beverages, and emotions. The olfactory system, which is responsible for processing and interpreting sensory information, is comprised of various components, including the olfactory receptors. Olfactory receptors are specialized taste and smell sensors that line the nasal passages and enable us to detect various scents. Olfactory receptor OR6B2 is one of these olfactory receptors, which is expressed in the maxillary gland, the olfactory nerve, and the brain.

OR6B2 is a G protein-coupled receptor (GPCR), which is a family of transmembrane proteins that play a crucial role in cellular signaling. GPCRs are involved in a wide range of physiological processes, including sensory perception, neurotransmitter signaling, and cell survival. OR6B2 is specifically involved in the processing and recognition of scents, which are mediated by neurotransmitters such as ethyl acetate, acetone, and pheromones.

OR6B2 is a strong candidate as a drug target due to its unique function in the olfactory system. Activation of OR6B2 by scents can elicit various behavioral and physiological responses, including increased neural activity in the brain and the release of neurotransmitters that can modulate mood, emotion, and memory. These effects make OR6B2 an attractive target for drug development. Additionally, OR6B2 is known to be involved in the regulation of various physiological processes, including female reproductive cycles, which makes it a potential biomarker for various diseases.

OR6B2 has been extensively studied in the context of olfactory disorders, neurodegenerative diseases, and cancer. OR6B2-deficient mice have been shown to have altered olfactory sensitivity and reduced neurotransmitter release, suggesting that OR6B2 plays a crucial role in normal olfactory function. In addition, increased expression of OR6B2 has been observed in various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. These findings support the idea that OR6B2 may be a potential drug target and biomarker for these diseases.

Furthermore, OR6B2 has also been shown to be involved in the regulation of cancer cell growth and metastasis. Increased expression of OR6B2 has been observed in various types of cancer, including breast, lung, and colon cancer. These findings suggest that OR6B2 may be a potential drug target for cancer treatment.

In conclusion, Olfactory receptor OR6B2 is a unique and highly promising drug target and biomarker. Its role in the olfactory system and its involvement in various physiological processes make it an attractive target for drug development. Additionally, its involvement in the regulation of olfactory disorders, neurodegenerative diseases, and cancer make it a promising biomarker for these conditions. Further research is needed to fully understand the mechanisms of OR6B2 and its potential as a drug target and biomarker.

Protein Name: Olfactory Receptor Family 6 Subfamily B Member 2

Functions: Odorant receptor

The "OR6B2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR6B2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR6B3 | OR6C1 | OR6C2 | OR6C3 | OR6C4 | OR6C65 | OR6C70 | OR6C74 | OR6C75 | OR6C76 | OR6F1 | OR6J1 | OR6K2 | OR6K3 | OR6M1 | OR6N1 | OR6N2 | OR6P1 | OR6Q1 | OR6R2P | OR6S1 | OR6T1 | OR6W1P | OR6X1 | OR6Y1 | OR7A10 | OR7A17 | OR7A5 | OR7C1 | OR7C2 | OR7D1P | OR7D2 | OR7D4 | OR7E104P | OR7E109P | OR7E121P | OR7E122P | OR7E125P | OR7E13P | OR7E140P | OR7E14P | OR7E155P | OR7E156P | OR7E19P | OR7E22P | OR7E24 | OR7E25P | OR7E29P | OR7E37P | OR7E41P | OR7E47P | OR7E5P | OR7E62P | OR7E84P | OR7E85BP | OR7E87P | OR7E91P | OR7E94P | OR7G1 | OR7G2 | OR7G3 | OR7M1P | OR8A1 | OR8B12 | OR8B2 | OR8B3 | OR8B4 | OR8B6P | OR8B7P | OR8B8 | OR8D1 | OR8D2 | OR8D4 | OR8F1P | OR8G1 | OR8G2P | OR8G3P | OR8G5 | OR8G7P | OR8H1 | OR8H2 | OR8H3 | OR8I2 | OR8J1 | OR8J3 | OR8K1 | OR8K3 | OR8K5 | OR8S1 | OR8U1 | OR8U3 | OR8U8 | OR9A1P | OR9A2 | OR9A4 | OR9G1 | OR9G4 | OR9G9 | OR9H1P | OR9I1